Interleukin-36 Receptor Antagonist class drugs
1 result
Spevigo (spesolimab-sbzo)
(spesolimab-sbzo)Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: SPEVIGO is indicated for the treatment of generalized pustular psoriasis (GPP) in adults and pediatric patients aged 12 and older, who weigh at least 40 kg.